The results of transcatheter mitral valve replacement
R. M. Sharifulin,
A. V. Bogachev-Prokofiev,
I. Yu. Zhuravleva,
T. P. Timchenko,
S. I. Zheleznev,
A. M. Karaskov https://doi.org/10.15829/1560-4071-2018-11-137-144
Abstract
Mitral insufficiency is one of the most common valvular pathology. In almost half of the patients, standard mitral valve replacement using extracorporeal circulation cannot be used due to the high risk of complications. In recent years, for this category of patients a method for transcatheter mitral valve replacement has been proposed. Now it is known about a few transcatheter prostheses for implantation
into the native mitral valve that are at the stage of preclinical or clinical trials. This article analyzes the results of the clinical use of prostheses for transcatheter mitral valve replacement.
About the Authors
R. M. Sharifulin
Meshalkin National Research Medical Center of RAS.
Russian Federation
Russian Federation
A. V. Bogachev-Prokofiev
Meshalkin National Research Medical Center of RAS.
Russian Federation
Russian Federation
I. Yu. Zhuravleva
Meshalkin National Research Medical Center of RAS.
Russian Federation
Russian Federation
T. P. Timchenko
Meshalkin National Research Medical Center of RAS.
Russian Federation
Russian Federation
S. I. Zheleznev
Meshalkin National Research Medical Center of RAS.
Russian Federation
Russian Federation
A. M. Karaskov
Meshalkin National Research Medical Center of RAS.
Russian Federation
Russian Federation
References
1. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016;102: 75–85. doi: 10.1136/heartjnl-2014-307020.
2. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. doi: 10.1093/eurheartj/ehx391.
3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006-8.
4. Kim WK, Hamm CW. Transcatheter aortic valve implantation in Germany. Clin Res Cardiol. 2018;107:81-7. doi: 10.1007/s00392-018-1297-0. doi: 1 10.1007/s00392-018-1297-0.
5. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674–81. doi: 10.1067/mtc.2001.117277.
6. Regueiro A, Granada JF, Dagenais F, et al. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J Am Coll Cardiol. 2017;69:2175-92. doi: 10.1016/j.jacc.2017.02.045.
7. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252-89. doi: 10.1016/j.jacc.2017.03.011.
8. Sorajja P, Maisano F. Percutaneous treatment for native mitral regurgitation. Progress in Cardiovascular Diseases. 2017;60(3):405-14. doi: 10.1016/j.pcad.2017.11.003
9. Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-Year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844-54. doi: 10.1016/j.jacc.2015.10.018.
10. Zhuravleva IYu, Bogachev-Prokophiev AV, Demidov DP, et al. Transcatheter implantation of mitral valve prostheses: current status of the problem. Kardiologiia. 2017;58(8):53–57. (In Russ.)
11. Paradis JM, Del Trigo M, Puri R, et al. Transcatheter valve‐in‐valve and valve‐in‐ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol. 2015;66(18):2019–2037. doi: 10.1016/j.jacc.2015.09.015.
12. Guerrero M, Dvir D, Himbert D, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv. 2016;9:1361-71. doi: 10.1016/j.jcin.2016.04.022.
13. Sondergaard L, De Backer O, Franzen OW, et al. First-in-human case of transfemoral CardiAQ mitral valve implantation. Circ Cardiovasc Interv. 2015;8:e002135.doi: 10.1161/CIRCINTERVENTIONS.115.002135.
14. Moat NE, Duncan A, Quarto C. Transcatheter mitral valve implantation: Tendyne. EuroIntervention. 2016;12:75–7. doi: 10.4244/EIJV12SYA20.
15. Cheung A, Banai S. Transcatheter mitral valve implantation: Tiara. EuroIntervention. 2016;12;70–2. doi: 10.4244/ EIJV12SYA18.
16. Bapat V, Lim ZY, Boix R, et al. The Edwards Fortis transcatheter mitral valve implantation system. EuroIntervention. 2015;11:73–5. doi: 10.4244/EIJV11SWA21.
17. Meredith I, Bapat V, Morriss J, et al. Intrepid transcatheter mitral valve replacement system: technical and product description. EuroIntervention. 2016;12:78–80. doi: 10.4244/EIJV12SYA21.
18. Navia JL, Baeza C, Maluenda G, et al. Transcatheter mitral valve replacement with the NaviGate stent in a preclinical model. EuroIntervention. 2017;13:1401-9. doi: 10.4244/EIJ-D-17-00210.
19. Abdelghani M, Onuma Y, Zeng Y, et al. The Sino Medical AccuFit transcatheter mitral valve implantation system. EuroIntervention. 2015;11:84–5. doi: 10.4244/EIJV11SWA26.
20. Zhuravleva IY, Nushtaev DV, Timchenko TV, et al. The concept of a device for the redo transcatheter mitral valve implantation. Sovremennye Tehnologii v Medicine. 2017;9(3):7–14. (In Russ.).
21. Bogachev-Prokophiev AV, Zhuravleva IYu, Sharifulin RM, et al. In vivo implantation of a new transcatheter prosthesis in mitral valve position. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2018; 22(1):22-8. (In Russ.).
22. Loger K, Pokorny S, Schaller T, et al. Novel stent design for transcatheter mitral valve implantation. Interact Cardiovasc Thorac Surg. 2018;26(2):190-5. doi: 10.1093/icvts/ivx289.
23. Bergsland J, Mirtaheri P, Hiorth N, et al. Review of the endovascular approach to mitral valve disease. Minimally Invasive Therapy. 2015;24:282–8. doi: 10.3109/13645706.2015.1065891.
24. Coylewright M, Cabalka AK, Malouf JA, et al. Percutaneous mitral valve replacement using a transvenous, transseptal approach: transvenous mitral valve replacement. JACC Cardiovasc Interv. 2015;8(6):850–7. doi: 10.1016/j.jcin.2015.01.028.
25. Sondergaard L, Brooks M, Ihlemann N,et al. Transcatheter mitral valve implantation via transapical approach: an early experience. Eur J Cardiothorac Surg. 2015;48(6):873-7. doi: 10.1093/ejcts/ezu546.
26. Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018;71:12-21. doi: 10.1016/j.jacc.2017.10.061.
27. Ussia GP, Cammalleri V, Mehta JL, et al. Transcatheter mitral valve replacement with a novel self-expandable prosthesis: single institutional experience procedural outcomes and follow-up. J Cardiovasc Med (Hagerstown). 2017;18(6):415-4. doi:10.2459/JCM.0000000000000513.
28. Barbanti M, Tamburino C. Transcatheter mitral valve implantation: CardiAQ. EuroIntervention. 2016;12:73–4. doi: 10.4244/EIJV12SYA19.
29. Banai S, Jolicoeur EM, Schwartz M, et al. Tiara: a novel catheter-based mitral valve bioprosthesis: initial experiments and short-term pre-clinical results. J Am Coll Cardiol. 2012;60:1430-1. doi: 10.1016/j.jacc.2012.05.047.
30. Verheye S, Cheung A, Leon M, et al. The Tiara transcatheter mitral valve implantation system. EuroIntervention 2015;11:71–2. doi: 10.4244/EIJV11SWA20.
31. Quarto C, Davies S, Duncan A, et al. Trans-catheter mitral valve implantation: 30-day outcome of first-in-man experience with an apically tethered device. Innovations (Phila) 2016; 11:174–8. doi: 10.1097/IMI.0000000000000278.
32. Duncan A, Daqa A, Yeh J, et al. Transcatheter mitral valve replacement: long-term outcomes of first-in-man experience with an apically tethered device – a case seres from a single centre. EuroIntervention. 2017;13:1047-57. doi:10.4244/EIJ-D-17-00154.
33. Muller DW, Farivar RS, Jansz P, et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 2017;69:381-91. doi: 10.1016/j.jacc.2016.10.068.
34. Barbanti M, Piazza N, Mangiafico S, et al. Transcatheter mitral valve implantation using the HighLife system. JACC Cardiovasc Interv. 2017;10:1662-70. doi:10.1016/j.jcin.2017.06.046.
35. Lange R, Piazza N. HighLife transcatheter mitral valve replacement. EuroIntervention. 2016;12:81-3. doi:10.4244/EIJV12SYA22.
36. Abdul-Jawad Altisent O, Dumont E, Dagenais F, et al. J. Transcatheter mitral valve implantation with the FORTIS device: Insights into the evaluation of device success. JACC: Cardiovasc Interv. 2015;8(7):994–5. doi.org/10.1016/j.jcin.2015.01.036.
37. Abdul-Jawad Altisent O, Dumont E, Dagenais F, et al. J. Initial experience of transcatheter mitral valve replacement with a novel transcatheter mitral valve: procedural and 6-month follow-up results. J Am Coll Cardiol. 2015;66(9):1011-9. doi: 10.1016/j.jacc.2015.06.1322.
38. Edwards Life Sciences, Corp. Edwards pauses enrollment in early stage mitral program. Edwards Lifesciences Corp. May 19, 2016. http:// www.edwards.com/fr/newsroom/Pages/ShowPR. aspx?PageGuid1⁄4%7B61d40c10-d690-45fa-b541- ab1f4806b975%7D ( March 1, 2017).
39. Regueiro A, Ye J, Fam N, et al. 2-Year Outcomes After Transcatheter Mitral Valve Replacement. JACC Cardiovasc Interv. 2017;10(16):1671-8. doi: 10.1016/j.jcin.2017.05.032.
40. Cheung A, Webb J, Verheye S, et al. Short- term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol. 2014;64:1814–9. doi: 10.1016/j.jacc.2014.06.1208.
Review
For citations:
Sharifulin R.M., Bogachev-Prokofiev A.V., Zhuravleva I.Yu., Timchenko T.P., Zheleznev S.I., Karaskov A.M. The results of transcatheter mitral valve replacement. Russian Journal of Cardiology. 2018;(11):137-144. (In Russ.) https://doi.org/10.15829/1560-4071-2018-11-137-144
Views:
1130
Email this article 